Sponsored by
Our medical editor, Stephen Western, put together what we feel are the most important stories from the SNO meeting!
There are a few reports of long term survivors with no recurrence after a few years - with Optune, Toca 511, and a new vaccine. If it were possible to combine these things, we may have something that is effective for the majority of patients! We are working on that - stay tuned!
Highlights from the Society for Neuro Oncology annual meeting, San Francisco California, November 16-19 2017
Click : https://virtualtrials.com/SNO_2017_Clinical_Highlights_treatments.cfm